integrin alpha-4/beta-7 antagonists (Quantum Intelligence)

N/A

Report date: 2025/03/20 16:03:57
NME

Base Information

Drug Nameintegrin alpha-4/beta-7 antagonists (Quantum Intelligence)
Drug Alias Nameintegrin alpha-4/beta-7 inhibitors (Quantum Intelligence)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-7 inhibitors
TargetsIntegrin alpha-4/beta-7
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuantum Intelligence Corp
China Registration ClassN/A

Develop Information

Active CompaniesQuantum Intelligence Corp
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A